Suppl Figure S11 from Inhibition of Microsomal Prostaglandin E2 Synthase Reduces Collagen Deposition in Melanoma Tumors and May Improve Immunotherapy Efficacy by Reducing T-cell Exhaustion
posted on 2023-07-31, 14:20authored byYasunari Fukuda, Sun-Hee Kim, Matias A. Bustos, Sung-Nam Cho, Jason Roszik, Jared K. Burks, Hong Kim, Dave S.B. Hoon, Elizabeth A. Grimm, Suhendan Ekmekcioglu
Figure S11 shows the effect of CAY10678 on the production of arachidonic acid metabolites from murine BrafV600E melanoma cells
Funding
HHS | NIH | National Cancer Institute (NCI)
Foundation for the National Institutes of Health (FNIH)
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF)
AIM at Melanoma (AIM at Melanoma Foundation)
Jim Malvo Foundation
History
ARTICLE ABSTRACT
Collagen is a predominant component of the extracellular matrix that may influence the tumor immune microenvironment for cancer progression. We present here that mPGES-1 has specific roles in regulating tumor immunity, associated with several collagen-related genes and propose that pharmacologic inhibition of mPGES-1 may hold therapeutic promise for improving immune checkpoint–based therapies.